16
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Prolactin Receptors in Dove Brain: Autoradiographic Analysis of Binding Characteristics in Discrete Brain Regions and Accessibility to Blood-Borne Prolactin

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Film autoradiography and densitometry were employed to obtain a detailed map of prolactin (PRL) receptor distribution in ring dove brain and to characterize the affinity, capacity, specificity, and in vivo saturability of <sup>125</sup>I-ovine PRL binding in individual brain regions. Significant specific binding was detected in choroid plexus and in a variety of forebrain and midbrain sites, with highest levels observed in the preoptic area, tuberoinfundibular region, lateral hypothalamic area, and the suprachiasmatic, paraventricular, and ventromedial hypothalamic nuclei. A comparison of PRL receptors in the choroid plexus, preoptic area, ventromedial nucleus, suprachiasmatic nucleus, and tuberal hypothalamus revealed significant regional differences in binding capacity, but no differences in binding affinity (K<sub>d</sub> = 0.4-0.9 n M; B<sub>max</sub> = 6-14 fmol/mg protein). Unlabelled ovine PRL proved to be an effective competitor of labelled ovine PRL at concentrations of 43 p M, 0.43 n M, and 4.3 n M in the choroid plexus and in 5 diencephalic areas. In contrast, no significant competition was observed in any of these brain areas in tests with unlabelled turkey GH, ovine GH, or ovine LH at similar concentrations. Unlabelled ovine PRL (37 nmol) significantly reduced the uptake of <sup>125</sup>I-ovine PRL (37 pmol) in the preoptic area, tuberal hypothalamus, and bed nucleus of the pallial commissure at 2 h after intravenous injection. In addition, specific binding of <sup>125</sup>I-ovine PRL in vitro was reduced by over 67% in these brain areas and in several other brain regions following a 7 day period of systemic ovine PRL administration. These results indicate that PRL receptors in different regions of the dove brain exhibit similar binding characteristics. In addition, they suggest that at least some of these PRL-sensitive brain loci are accessible to blood-borne hormone.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1993
          1993
          08 April 2008
          : 57
          : 4
          : 738-750
          Affiliations
          Department of Biological Sciences University of Wisconsin-Milwaukee, Milwaukee, Wisc., USA
          Article
          126432 Neuroendocrinology 1993;57:738–750
          10.1159/000126432
          8367036
          89d41d37-2999-457b-b78a-5dad31927e2f
          © 1992 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 27 August 1992
          : 23 October 1992
          Page count
          Pages: 13
          Categories
          Original Paper

          Endocrinology & Diabetes,Neurology,Nutrition & Dietetics,Sexual medicine,Internal medicine,Pharmacology & Pharmaceutical medicine
          Prolactin receptors,Preoptic area,Choroid plexus,Hypothalamus,Prolactin,Blood-brain barrier

          Comments

          Comment on this article